Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)

이호균 ,  정일 ,  박병서 외 9명

Diabetes and Metabolism Journal

2024 .01

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)

Tomoyuki Kawada

Diabetes and Metabolism Journal

2022 .07

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)

Kim Hwi Seung ,  이우제

Diabetes and Metabolism Journal

2022 .07

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43: 158-73)

이지연 ,  강은석

Diabetes and Metabolism Journal

2019 .01

Off-target Effects of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor in Cardiovascular Disease

Jiwon Hwang ,  Dong-Bin Kim ,  Hun-Jun Pa 외 1명

Korean Circulation Journal

2020 .01

Antidiabetic effect of Luffa cylindrical extract against the streptozotocin induced diabetes via alteration of glucose transporter 2 and sodium-glucose cotransporter 1

Vikas KUMAR ,  Vastvikta SAHAI

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

SGLT2 억제제와 케톤산증: 발생기전과 대처

구윤희

대한내과학회지

2017 .01

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction? (Diabetes Metab J 2019;43:785-93)

Ch ,  istian S. Göbl ,  And 외 2명

Diabetes and Metabolism Journal

2020 .01

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction? (Diabetes Metab J 2019;43:785-93)

양예슬 ,  정혜승

Diabetes and Metabolism Journal

2020 .01

GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)

구보경 /Bo Kyung Koo

Diabetes and Metabolism Journal

2015 .01

GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)

홍준화 /JunHwa Hong ,  구본정 /Bon-Jeong Ku ,  송민호 /Min Ho Shong

Diabetes and Metabolism Journal

2015 .01

Sodium-Glucose Cotransporter 2 Inhibitor Improves Neurological Outcomes in Diabetic Patients With Acute Ischemic Stroke

Wookjin Yang ,  Jeong-Min Kim ,  Matthew Chung 외 8명

대한뇌졸중학회지

2024 .05

Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90-6)

백인경

Diabetes and Metabolism Journal

2019 .01

Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90-6)

구보경

Diabetes and Metabolism Journal

2019 .01

Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator

민세희 ,  송도경 ,  이찬희 외 2명

Endocrinology and Metabolism

2024 .02

Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea (Diabetes Metab J 2024;48:482-6)

노은후 ,  곽수헌

Diabetes and Metabolism Journal

2024 .07

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors

정찬희

Endocrinology and Metabolism

2021 .01

Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J 2015;39:147-53)

오태정 ,  민세희 ,  안창호 외 5명

Diabetes and Metabolism Journal

2015 .01

Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)

윤재승 ,  고승현

Diabetes and Metabolism Journal

2017 .01